Magrit Phase Iii Trial: Mage-A3 Antigen-Specific Cancer Immunotherapy (Asci) As Adjuvant Therapy In Patients With Completely Resected Stage Ib-Iiia Nsclc.
JOURNAL OF CLINICAL ONCOLOGY(2011)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2011)